103 related articles for article (PubMed ID: 15130519)
21. Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
Nakayama H; Sano T; Motegi A; Oyama T; Nakajima T
Pathol Int; 2005 Nov; 55(11):707-15. PubMed ID: 16271083
[TBL] [Abstract][Full Text] [Related]
22. Estrogenic effect on the expression of estrogen receptor, COUP-TF, and lactoferrin mRNA in developing mouse tissues.
Shigeta H; Newbold RR; McLachlan JA; Teng C
Mol Reprod Dev; 1996 Sep; 45(1):21-30. PubMed ID: 8873065
[TBL] [Abstract][Full Text] [Related]
23. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
[TBL] [Abstract][Full Text] [Related]
24. Suppressors of cytokine signaling proteins in human preterm placental tissues.
Blumenstein M; Keelan JA; Bowen-Shauver JM; Mitchell MD
J Mol Endocrinol; 2005 Aug; 35(1):165-75. PubMed ID: 16087730
[TBL] [Abstract][Full Text] [Related]
25. Stage-specific expression of estrogen receptor subtypes and estrogen responsive finger protein in preimplantational mouse embryos.
Hiroi H; Momoeda M; Inoue S; Tsuchiya F; Matsumi H; Tsutsumi O; Muramatsu M; Taketani Y
Endocr J; 1999 Feb; 46(1):153-8. PubMed ID: 10426580
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus.
Brandenberger AW; Tee MK; Lee JY; Chao V; Jaffe RB
J Clin Endocrinol Metab; 1997 Oct; 82(10):3509-12. PubMed ID: 9329394
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
28. [Expression and localization of estrogen receptor ERalpha and the kinds of ERbeta mRNA on placenta].
Luo D; Liu SY; Xing AY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):769-72. PubMed ID: 17037748
[TBL] [Abstract][Full Text] [Related]
29. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.
Couse JF; Lindzey J; Grandien K; Gustafsson JA; Korach KS
Endocrinology; 1997 Nov; 138(11):4613-21. PubMed ID: 9348186
[TBL] [Abstract][Full Text] [Related]
30. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues.
Cheung CP; Yu S; Wong KB; Chan LW; Lai FM; Wang X; Suetsugi M; Chen S; Chan FL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1830-44. PubMed ID: 15598686
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
[TBL] [Abstract][Full Text] [Related]
32. A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15.
Nakasato N; Ikeda K; Urano T; Horie-Inoue K; Takeda S; Inoue S
Biochem Biophys Res Commun; 2006 Dec; 351(2):540-6. PubMed ID: 17069755
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
Nakamura Y; Suzuki T; Miki Y; Tazawa C; Senzaki K; Moriya T; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
Mol Cell Endocrinol; 2004 Apr; 219(1-2):17-26. PubMed ID: 15149723
[TBL] [Abstract][Full Text] [Related]
34. Estrogen actions and in situ synthesis in human vascular smooth muscle cells and their correlation with atherosclerosis.
Nakamura Y; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):263-8. PubMed ID: 15860269
[TBL] [Abstract][Full Text] [Related]
35. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.
Dong XY; Fu X; Fan S; Guo P; Su D; Dong JT
Biochem J; 2012 Jun; 444(3):581-90. PubMed ID: 22452784
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein.
Arai N; Ström A; Rafter JJ; Gustafsson JA
Biochem Biophys Res Commun; 2000 Apr; 270(2):425-31. PubMed ID: 10753641
[TBL] [Abstract][Full Text] [Related]
37. Interaction of steroid receptor coactivators and estrogen receptors in the human placenta.
Kim SC; Park MN; Lee YJ; Joo JK; An BS
J Mol Endocrinol; 2016 Apr; 56(3):239-47. PubMed ID: 26733313
[TBL] [Abstract][Full Text] [Related]
38. Pit-1/growth hormone factor 1 splice variant expression in the rhesus monkey pituitary gland and the rhesus and human placenta.
Schanke JT; Conwell CM; Durning M; Fisher JM; Golos TG
J Clin Endocrinol Metab; 1997 Mar; 82(3):800-7. PubMed ID: 9062486
[TBL] [Abstract][Full Text] [Related]
39. Sex steroid receptors in rheumatoid arthritis.
Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
Zou W; Wang J; Zhang DE
Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
